Next-generation sequencing for the detection of microorganisms present in human donor corneal preservation medium [0.03%]
下一代测序在人捐献角膜保存液中微生物检测中的应用
Mohit Parekh,Davide Borroni,Vito Romano et al.
Mohit Parekh et al.
Objective: To detect the presence of microorganisms in the storage media of human donor corneas using next-generation sequencing method. Methods: ...
Effect of total anti-VEGF treatment exposure on patterns of choroidal neovascularisation assessed by optical coherence tomography angiography in age-related macular degeneration: a retrospective case series [0.03%]
抗VEGF治疗总量对年龄相关性黄斑变性新生血管形态影响的光学相干断层扫描血管成像研究：回顾性病例系列研究
Livia Faes,Zaria Ali,Siegfried Wagner et al.
Livia Faes et al.
Objective: To compare clinical characteristics of patients suffering from neovascular age-related macular degeneration (nAMD) with mature and immature choroidal neovascularisation (CNV) as assessed by optical coherence to...
Refractive outcomes following cataract surgery in patients who have had myopic laser vision correction [0.03%]
激光视力矫正患者的白内障手术屈光结果
Chung Shen Chean,Boon Kang Aw Yong,Samuel Comely et al.
Chung Shen Chean et al.
Objective: Prediction errors are increased among patients presenting for cataract surgery post laser vision correction (LVC) as biometric relationships are altered. We investigated the prediction errors of five formulae a...
Repeatability of choroidal thickness measurements with Spectralis OCT images [0.03%]
Spectralis OCT图像测量脉络膜厚度的重复性
Jason K Lau,Sin Wan Cheung,Michael J Collins et al.
Jason K Lau et al.
Objective: To investigate the repeatability of choroidal thickness measurements determined from enhanced depth imaging optical coherence tomography (EDI-OCT) images of eyes after wearing single-vision spectacles (SV) and ...
The profile of sight-threatening diabetic retinopathy in patients attending a specialist eye clinic in Hangzhou, China [0.03%]
中国杭州专科眼科就诊糖尿病视网膜病变患者的临床特征分析
Raju Sapkota,Zhiqing Chen,Dingchang Zheng et al.
Raju Sapkota et al.
Background/aims: To examine the profile of diabetic retinopathy, awareness and self-help in patients attending a specialist eye clinic in Hangzhou, China. ...
Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema [0.03%]
雷力研究：雷珠单抗治疗糖尿病黄斑水肿的患者的预后效果研究
Usha Chakravarthy,Ian Pearce,Sanjiv Banerjee et al.
Usha Chakravarthy et al.
Background/aims: The RELIGHT clinical trial used an individualised treatment regimen of ranibizumab to treat diabetic macular oedema (DMO). We report findings from two patient-reported outcome instruments. ...
Traumatic hyphaema in children: a retrospective and prospective study of outcomes at an Australian paediatric centre [0.03%]
儿童眼外伤性玻璃体出血：澳大利亚儿科中心回顾性和前瞻性研究的预后结果
Michael D Richards,Kate Barnes,Anne-Marie E Yardley et al.
Michael D Richards et al.
Objective: This study aims to evaluate the presenting characteristics, management, outcomes and complications for paediatric traumatic hyphaema in Western Australia. ...
Xiaoxuan Liu,Sai Kolli,Peter McDonnell et al.
Xiaoxuan Liu et al.
Objective: Herpes simplex keratitis (HSK) is a sight-threatening disease and a leading cause of infectious corneal blindness. Involving patients in setting the research agenda maximises patient benefit and minimises resea...
Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study [0.03%]
关于法国常规临床实践中湿性年龄相关性黄斑变性患者的玻璃体内阿柏西普注射疗法的疗效和安全性：RAINBOW研究的12个月结果
Michel Weber,Laurent Velasque,Florence Coscas et al.
Michel Weber et al.
Background/aims: To monitor treatment-naïve patients with wet age-related macular degeneration (wet AMD) receiving intravitreal aflibercept (IVT-AFL) in France. ...
Five-year outcomes of retinal vein occlusion treated with vascular endothelial growth factor inhibitors [0.03%]
抗血管内皮生长因子治疗视网膜静脉阻塞5年的结局
Kimberly Spooner,Samantha Fraser-Bell,Thomas Hong et al.
Kimberly Spooner et al.
Purpose: Report 5-year outcomes of patients receiving anti-vascular endothelial growth factor (VEGF) for the treatment of macular oedema secondary to retinal vein occlusion (RVO. ...